Sabrina Cohen Foundation Thanks Stem Cell Researchers
By Dr. Matthew Watson
I'm proud to use every available resource at our disposal, including this blog, to highlight the efforts of the charity we support - especially during this holiday season.
I would be so delighted to have you join me in supporting Sabrina Cohen and her efforts. You can start by buying next year's calendar!
The Sabrina Cohen Foundation
The Sabrina Cohen Foundation for Stem Cell Research (SCF) is an internationally recognized nonprofit organization dedicated to building a global network of top scientists and clinicians in the field of Regenerative Medicine, while simultaneously funding cutting edge research and innovative therapies that will reverse spinal cord injury and effectively treat other impairments of the Central Nervous System.
The ‘CELLebrity’ Doctors Calendar
The 2012 CELLebrity Doctors calendar is now available for purchase from http://www.CELLebrityDocsCalendar.com. All proceeds from calendar sales benefit the Sabrina Cohen Foundation for Stem Cell Research, a 501c3 non-profit organization directly funding stem cell clinical research.
--Lee
_________________________________________________________________
On the night of November 12, David Porosoff’s Artrageous Gallery hotspot was converted into something likely never imagined -- a hotbed of stem cell research. Sabrina Cohen fused the vividly artistic backdrop and venue with gambling, cuban music, great food, and beautiful people all to further her mission of raising money and awareness for stem cell research.
Dr. Sally Temple with Sabrina Cohen |
Dubbed the Havana Casino Night, the event had several highlights including the granting of the 2011 Sabrina Cohen Foundation award to stem cell researcher Dr. Sally Temple.
Representing the 3rd recipient of the annual SCF award, Dr. Sally Temple is studying how neural progenitor cells may be employed to create cell-based therapies for neurodegenerative disorders. Dr. Temple is the co-Founder and Scientific Director of the Neural Stem Cell Institute located in Rensselaer, NY. NSCI is the first independent, non-profit stem cell research institute in the USA.
The night, sponsored in part by DMR, Evensky & Katz and Harke Clasby & Bushman, raised $10,000 which will be dedicated toward next year’s SCF Award for Stem Cell Research.
The event also marked the lauch of the the Foundation’s 2012 CELLebrity Doctors Calendar, this year featuring women in the field of stem cell research. The calendar features academics, industry executives, physicians, and advocates primarily from the United States but also representing Sweden, Australia and Canadian covergirl, Dr. Fiona Costello.
“In science you don't have to accept anything anyone tells you, you can come up with a hypothesis and test it yourself. And you can be the first one to do it,” says Dr. Costello, whose research focus is on multiple sclerolsis and other impairments of the central nervous system.
“Stem cell science is often accused of being ‘hyped,” says Cohen, “but that doesn’t necessarily translate into monetary support for or society recognition of the enormous contributions made by stem cell resarchers. They often toil in anonymity making significant discoveries at great personal sacrifice. I consider it my job to find a way to financially support their work and bring profile to them as people.”
The ‘CELLebrity’ Doctors Calendar
The 2012 CELLebrity Doctors calendar is now available for purchase from http://www.CELLebrityDocsCalendar.com. All proceeds from calendar sales benefit the Sabrina Cohen Foundation for Stem Cell Research, a 501c3 non-profit organization directly funding stem cell clinical research.
The Sabrina Cohen Foundation
The Sabrina Cohen Foundation for Stem Cell Research (SCF) is an internationally recognized nonprofit organization dedicated to building a global network of top scientists and clinicians in the field of Regenerative Medicine, while simultaneously funding cutting edge research and innovative therapies that will reverse spinal cord injury and effectively treat other impairments of the Central Nervous System.
Sabrina Cohen is the Executive Director and President of the foundation. She graduated from the University of Miami with a degree in Communications, double majoring in Advertising and Psychology, and holds a post-graduate degree in Copywriting from the Miami Ad School. She is a C5 Quadriplegic, as the result of a spinal cord injury from a car accident in 1992. In 2006, she established SCF to raise funds for research because she believes the field of Regenerative Medicine will lead to the greatest advances of our time. Sabrina is a Motivational Speaker & Spokesperson continuously speaking in schools, universities and community centers. She has spoken at scientific conferences around the country, including the "World Stem Cell Summit" at the University of Wisconsin, Harvard University, Stanford University, Baylor College of Medicine at the University of Texas, and at the United Nations. Sabrina believes her wheelchair is a vehicle to promote change.
Sabrina Cohen was recognized by WebMD Magazine as a 2009 "American Health Hero”. Sabrina is currently available for interviews highlighting the 2012 “CELLebrity” Doctors Calendar.
Source:
http://feeds.feedburner.com/CellTherapyBlog
- Commercialization of Regenerative Medicine: Learning from Spin-Outs - April 28th, 2013
- 2013 Annual Regenerative Medicine Industry Report - April 21st, 2013
- Cell Therapy Blog welcomes 2013 - January 6th, 2013
- The Accuracy of Adipose Stem Cell Doses - December 23rd, 2012
- A proposed 6-step platform for the cell therapy industry to consider in combating non-compliant cell therapy treatments - December 16th, 2012
- The ROI on pant-wearing and other social media tips - December 16th, 2012
- Six steps to fighting non-compliant cell therapy treatments. --- The stuff of grey shades, spades, ivory towers and (ahem) balls. - December 2nd, 2012
- Cell Therapy Industry Group Welcomes its 4,000th member - November 11th, 2012
- GEN's "Cellular Therapy Wave Finally Cresting". An overview and data set. - November 4th, 2012
- CIRM addresses some tough questions. Is it all just glass towers and basic research? - October 21st, 2012
- Cell therapy portfolio outperforms major indices year-to-date - October 14th, 2012
- The cost of clinical trial data bias/loss, FDA's new job and the need for bold leadership. - September 30th, 2012
- Anticipated short-term cell therapy industry clinical milestones - September 30th, 2012
- Two lessons I learned this week. - September 16th, 2012
- Are some cell counts too good to be true? Why some companies' product data may mislead. - September 2nd, 2012
- Is the cell therapy sector outperforming the major indices? - August 12th, 2012
- FDA 1. RSI 0. Regenerative Sciences (Regenexx) vs FDA (2012) - July 29th, 2012
- Bioreactor Design and Bioprocess Controls for Industrialized Cell Processing - June 17th, 2012
- Industry-sponsored cardiovascular cell therapies. Some metrics. - May 27th, 2012
- Cell-based Cancer Immunotherapies. Some metrics.. - May 20th, 2012
- Another > $100M month for companies in the cell therapy space - May 6th, 2012
- Predicting the Success of the Late-Stage Cell-Based Cancer Immunotherapy Pipeline? - March 11th, 2012
- 2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned? - January 1st, 2012
- Inactive and recently failed or terminated phase III or II/III cell therapy trials - December 18th, 2011
- Recently approved cell therapy products - December 18th, 2011
- Active phase III or II/III cell therapy trials - December 11th, 2011
- Commercializing Cell-based Regenerative Medicines - November 13th, 2011
- Cell Therapy & Regenerative Medicine Domains Available - September 25th, 2011
- Commercial-stage Cell Therapy Companies and Products - September 18th, 2011
- Potential far-reaching implications of the ongoing fight over point-of-care autologous cell therapy - September 18th, 2011
- Good Data? $100. Good Product Development? $100. Good Commercialization Strategy? Priceless. - August 14th, 2011
- Clinical trial costs - July 31st, 2011
- Cell Therapy's Got Talent Technology Showcase - A Call for Cell Therapy Manufacturing Technology Presentations - July 10th, 2011
- In vivo cell trafficking just took a leap forward - July 3rd, 2011
- Cell Therapies: Commercializing a New Class of Biopharmaceuticals - February 12th, 2011
- The LinkedIn Cell Therapy Industry Group - 1,000 members strong - January 15th, 2011
- Careers in cell therapy & regenerative medicine - October 11th, 2010
- FDA files injunction again Regenerative Sciences citing Regenexx violates regulations - August 12th, 2010
- The changing face of PR and why it matters to regenmed - June 12th, 2010
- Biotech tax credit appears perfectly designed for cell therapy companies to recoup research dollars spent in 2009-10 - May 22nd, 2010
- Google to Invest in Regenerative Medicine - May 5th, 2010
- Latest Cell Therapy Approval by FDA. Dendreon's Provenge. - April 30th, 2010
- Stem cells for a Webby! - April 28th, 2010